One Of Linus Ullmark's Biggest Mental Health Supporters Opens Up About His Own Struggles - The Hockey News

The Ottawa Senators have been one of the top stories of the season, as they own a 5-1-0 record and sit atop the Atlantic Division despite injuries to major players like Jake Sanderson, William Eklund and Artem Zub and after losing former captain Brady Tkachuk in a trade for only draft picks over the summer. Holding it all together has been goalie Linus Ullmark, who has gone 5-0 with a .948 save percentage and 1.27 goals against average, making him one of the early frontrunners for the Vezina Trophy.

Skip to Content Subscribe FAQ My Account Manage My Subscriptions News Local News Public Service National World True Crime Weather Archives Tariffs Opinion Editorials Letters Submit a Letter Columnists Submit an Opinion Column Food Local Food Reviews Arts Local Arts Music Local Reviews Movies Television TV Listings Books Celebrity Cappies Public Service Defence Watch Fixing Byward Sports Ottawa Senators NHL PWHL More Hockey Junior Hockey Local Sports Ottawa Redblacks CFL NFL Baseball Basketball NBA Tennis Golf Life Savings Newsletters Lives Told Tails Told Shopping Ottawa Citizen Store Puzzmo Obituaries Place an Obituary Place an In Memoriam Longreads Diversions Comics Puzzles New York Times Crossword Contests Healthing ePaper Driving Vehicle Research Reviews News Gear Guide Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Browse Listings Place an Ad Business Card Directory Celebrations Real Estate Marketplace Pet Posts and Adoptions Working Business Ads This Week's Flyers Manage Print Subscription National Capital Region's Top Employers Inside Ottawa Hospital Social Scene Profile Settings My Subscriptions My Offers

Bioengineer.org news storyFor millions of people living with HIV, antiretroviral therapy has transformed a once-fatal infection into a manageable chronic condition. Yet the very drugs that suppress the virus can carry quiet costs, and one of the most insidious is bone loss. Tenofovir disoproxil fumarate, or TDF, has been a cornerstone of HIV treatment worldwide for two decades, prized for its potency, durability, and low cost. But a growing body of evidence has linked TDF exposure to measurable reductions in bone mineral density, raising an increasingly urgent clinical question: once bone has been lost on a TDF-based regimen, can it be recovered? A new prospective cohort study, published in BMC Infectious Diseases, offers some of the most detailed longitudinal evidence to date that the answer, for many patients, is yes. The research team enrolled 223 virologically suppressed men living with HIV who had low bone mineral density while taking TDF-based antiretroviral therapy.